BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23174882)

  • 1. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
    Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
    Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
    Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
    J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
    Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
    J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.
    Ehlers A; Oker E; Bentink S; Lenze D; Stein H; Hummel M
    Leukemia; 2008 Apr; 22(4):835-41. PubMed ID: 18256685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
    Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
    Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Schwering I; Bräuninger A; Klein U; Jungnickel B; Tinguely M; Diehl V; Hansmann ML; Dalla-Favera R; Rajewsky K; Küppers R
    Blood; 2003 Feb; 101(4):1505-12. PubMed ID: 12393731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
    Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
    Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.
    Atayar C; Poppema S; Blokzijl T; Harms G; Boot M; van den Berg A
    Am J Pathol; 2005 Jan; 166(1):127-34. PubMed ID: 15632006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
    Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
    Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
    Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
    Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
    Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
    Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
    Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.